# EDGAR Filing Document

**Accession Number:** 0001421744
**File Stem:** 0001872856-26-000157
**Filing Date:** 2026-5
**Character Count:** 5068
**Document Hash:** 2e391ad630d573d5b4ac7a7fa2dc96ec
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001872856-26-000157.hdr.sgml**: 20260501

**ACCESSION NUMBER**: 0001872856-26-000157

**CONFORMED SUBMISSION TYPE**: C/A

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20260501

**DATE AS OF CHANGE**: 20260501

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Cytonics Corp
- **CENTRAL INDEX KEY:** 0001421744
- **STANDARD INDUSTRIAL CLASSIFICATION:** BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 208883869
- **STATE OF INCORPORATION:** FL

**FILING VALUES:**
- **FORM TYPE:** C/A
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 020-36849
- **FILM NUMBER:** 26932138

**BUSINESS ADDRESS:**
- **STREET 1:** 658 W INDIANTOWN RD
- **STREET 2:** SUITE 214
- **CITY:** JUPITER
- **STATE:** FL
- **ZIP:** 33458-7535
- **BUSINESS PHONE:** (561) 575-4451

**MAIL ADDRESS:**
- **STREET 1:** 658 WEST INDIANTOWN ROAD
- **STREET 2:** SUITE 214
- **CITY:** JUPITER
- **STATE:** FL
- **ZIP:** 33458

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** CYTONICS CORP
- **DATE OF NAME CHANGE:** 20071219

### Attached PDF Documents

**Attachment 1:** `cytonicsformca050126.pdf`

_No text found in this document._

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM C

### UNDER THE SECURITIES ACT OF 1933

### Issuer Information

**Is this an amendment?** Yes

**Nature of Amendment:** We are amending this filing to update certain financial information and other disclosures and to incorporate 2025 audited financials.

**Name of Issuer:** Cytonics Corp

**Legal Status:** Corporation

**Jurisdiction of Incorporation/Organization:** FL

**Date of Organization:** 07-19-2006

**Physical Address:** 658 WEST INDIANTOWN ROAD, JUPITER, FL, 33458

**Issuer Website:** www.cytonics.com

**Is there a Co-Issuer?:** No

**Intermediary Name:** DEALMAKER SECURITIES LLC

**Intermediary CIK:** 0001872856

**Intermediary File Number:** 008-70756

**Intermediary CRD Number:** 000315324

### Offering Information

**Compensation to Intermediary:** The Company will pay DealMaker Securities LLC an 8.5% cash commission fee based on the dollar amount of the Securities sold in the Offering. There is also a one-time $13,750 fee and $12,000 monthly fee payable to DealMaker Securities and/or its affiliates.

**Financial Interest in Issuer:** None

**Type of Security Offered:** Common Stock

**Number of Securities Offered:** 2450

**Price per Security:** $4.00

**Target Offering Amount:** $10,000.00

**Oversubscription Accepted:** Yes

**Oversubscription Allocation Type:** Other

**Description of Oversubscription:** At the Company's discretion

**Maximum Offering Amount:** $5,000,000.00

**Deadline to Reach Target Amount:** 02-24-2027

### Annual Report Disclosure Requirements

**Current Number of Employees:** 1.00

**Total Assets (Most Recent Fiscal Year):** $2,412,710.00

**Total Assets (Prior Fiscal Year):** $2,777,933.00

**Cash & Cash Equivalents (Most Recent Fiscal Year):** $2,147,326.00

**Cash & Cash Equivalents (Prior Fiscal Year):** $2,432,955.00

**Accounts Receivable (Most Recent Fiscal Year):** $50,000.00

**Accounts Receivable (Prior Fiscal Year):** $50,000.00

**Short-Term Debt (Most Recent Fiscal Year):** $0.00

**Short-Term Debt (Prior Fiscal Year):** $0.00

**Long-Term Debt (Most Recent Fiscal Year):** $0.00

**Long-Term Debt (Prior Fiscal Year):** $0.00

**Revenues/Sales (Most Recent Fiscal Year):** $260,000.00

**Revenues/Sales (Prior Fiscal Year):** $306,669.00

**Cost of Goods Sold (Most Recent Fiscal Year):** $0.00

**Cost of Goods Sold (Prior Fiscal Year):** $0.00

**Taxes Paid (Most Recent Fiscal Year):** $0.00

**Taxes Paid (Prior Fiscal Year):** $0.00

**Net Income (Most Recent Fiscal Year):** $-8,585,155.00

**Net Income (Prior Fiscal Year):** $-4,526,921.00

**Jurisdictions Offered:**

ALABAMA, ALASKA, ARIZONA, ARKANSAS, CALIFORNIA, COLORADO, CONNECTICUT, DELAWARE, DISTRICT OF COLUMBIA, FLORIDA, GEORGIA, HAWAII, IDAHO, ILLINOIS, INDIANA, IOWA, KANSAS, KENTUCKY, LOUISIANA, MAINE, MARYLAND, MASSACHUSETTS, MICHIGAN, MINNESOTA, MISSISSIPPI, MISSOURI, MONTANA, NEBRASKA, NEVADA, NEW HAMPSHIRE, NEW JERSEY, NEW MEXICO, NEW YORK, NORTH CAROLINA, NORTH DAKOTA, OHIO, OKLAHOMA, OREGON, PENNSYLVANIA, PR, RHODE ISLAND, SOUTH CAROLINA, SOUTH DAKOTA, TENNESSEE, TEXAS, UTAH, VERMONT, VIRGINIA, WASHINGTON, WEST VIRGINIA, WISCONSIN, WYOMING, ALBERTA, BRITISH COLUMBIA, MANITOBA, NEW BRUNSWICK, NEWFOUNDLAND, NOVA SCOTIA, ONTARIO, PRINCE EDWARD ISLAND, QUEBEC, SASKATCHEWAN, YUKON TERRITORY, ISRAEL

### Signatures

**Issuer:** Cytonics Corp

**Signature:** Anjun (Joey) Bose

**Title:** CEO

---

**Signature:** Anjun (Joey) Bose

**Title:** Director, CEO, Principal Executive Officer, Principal Accounting and Financial Officer

**Date:** 05-01-2026

---

**Signature:** Gaetano Scuderi

**Title:** Director

**Date:** 05-01-2026

---

**Signature:** Gordon Ramseier

**Title:** Director

**Date:** 05-01-2026

---

**Signature:** Tracy Goeken

**Title:** Director

**Date:** 05-01-2026